Hypertensive Emergency

• Loss of autoregulation and endothelial injury: At severely elevated pressures, the endothelium sustains direct mechanical injury from shear stress, leading to increased vascular permeability, extravasation of fibrin and platelets, and activation of coagulation cascades. This "acute arterial necrosis" or fibrinoid necrosis is pathognomonic for hypertensive emergency and distinguishes it from chronic hypertensive changes. The damaged endothelium releases tissue factor and von Willebrand factor, triggering thrombotic microangiopathy.

• Activation of the renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system: Acute renal hypoperfusion activates renin release, creating a vicious cycle of increased angiotensin II production, vasoconstriction, sodium retention, and further pressure elevation. Sympathetic activation increases catecholamine levels, enhancing cardiac output and peripheral resistance. This positive feedback loop perpetuates escalating hypertension unless interrupted by intervention.

• Acute cerebral and renal microvascular injury: In the brain, failure of autoregulation leads to hypertensive encephalopathy through posterior reversible encephalopathy syndrome (PRES), characterized by cerebral edema predominantly affecting the parieto-occipital regions. In the kidneys, acute tubular necrosis and arteriolar necrosis cause acute kidney injury with hematuria, proteinuria, and schistocytes on blood smear (microangiopathic hemolytic anemia). Increased glomerular filtration pressure causes endothelial damage and protein leak, worsening renal function.

• Myocardial and vascular stress: Extreme afterload elevation increases myocardial oxygen demand, precipitating acute coronary syndrome or acute heart failure with pulmonary edema. In large vessels, transmural inflammation and necrosis can cause aortic dissection, acute aortic regurgitation, or rupture.

• Primary (essential) hypertension: Accounts for 90% of hypertensive emergencies; typically requires decades of poorly controlled hypertension to develop acute complications; emergency presentation often reflects medication non-adherence or nonadherence periods.

• Secondary hypertension with abrupt elevation:
• Renovascular disease (atherosclerotic renal artery stenosis or fibromuscular dysplasia)
• Pheochromocytoma: Catecholamine surge causes dramatic, paroxysmal hypertension with severe complications
• Preeclampsia/eclampsia: Hypertension with proteinuria and seizures in pregnant women
• Renal parenchymal disease: Acute glomerulonephritis (IgA nephropathy, ANCA-associated vasculitis, lupus nephritis)
• Coarctation of the aorta: Fixed obstruction with upstream hypertension
• Hyperthyroidism: Increased adrenergic sensitivity
• Obstructive sleep apnea: Nocturnal sympathetic surges

• Medication-related triggers:
• Sympathomimetics: decongestants (pseudoephedrine), amphetamines, cocaine
• NSAIDs: Impair renal vasodilation and sodium excretion
• Oral contraceptives: Estrogen-induced RAAS activation
• Cyclosporine: Direct vasoconstriction and renal toxicity
• Abrupt withdrawal of antihypertensives: Particularly beta-blockers and clonidine cause rebound hypertension

• Acute precipitants:
• Acute coronary syndrome
• Acute ischemic or hemorrhagic stroke
• Monoamine oxidase (MAO) inhibitor interactions with sympathomimetics or tyramine-rich foods
• Intracranial pathology (subarachnoid hemorrhage, tumors)

• Special populations at higher risk:
• African American ancestry: Earlier and more severe hypertensive complications
• Chronic kidney disease: Impaired sodium excretion and RAAS dysregulation
• Younger patients (age <40): Suggests secondary etiology requiring investigation

• Neurologic manifestations (most common presenting complaint):
• Headache: Severe, often occipital, may be accompanied by visual changes (scotomas, blurred vision, photopsia)
• Confusion, altered mental status, lethargy: Reflecting hypertensive encephalopathy
• Focal neurologic deficits: Stroke (ischemic or hemorrhagic)
• Seizures: Typically generalized; indicate severe encephalopathy
• Posterior reversible encephalopathy syndrome (PRES): Visual disturbances, headache, confusion in classic distribution

• Cardiovascular symptoms:
• Chest pain: Crushing quality suggests acute coronary syndrome or aortic dissection
• Dyspnea: Acute pulmonary edema with pink frothy sputum (cardiogenic)
• Palpitations: Atrial fibrillation from acute left atrial stretch

• Renal manifestations:
• Flank or back pain: May suggest renal infarction or renal artery dissection
• Hematuria, oliguria: Acute glomerulonephritis or acute tubular necrosis

• Physical examination findings:
• Severe hypertension: SBP typically >180 mmHg, DBP typically >120 mmHg
• Hypertensive retinopathy: Flame hemorrhages, cotton-wool spots, hard exudates, papilledema (Keith-Wagener Grade III-IV changes); papilledema specifically indicates end-organ damage and emergency status
• Signs of pulmonary edema: Bilateral crackles on auscultation, elevated jugular venous pressure, S3 gallop
• Neurologic signs: Focal deficits, confusion, seizure activity
• Aortic regurgitation murmur: High-pitched early diastolic murmur at left sternal border (aortic dissection)
• Asymmetric blood pressures in extremities: Suggests aortic dissection
• Signs of hemolysis: Jaundice, pallor from microangiopathic hemolytic anemia

• Blood pressure measurement:
• Obtain in both arms; persistently elevated readings (>180/120 mmHg) on multiple occasions confirm severe elevation
• Initial measurement should be taken after 5 minutes of quiet rest; repeat if significantly elevated
• Home readings often underestimate severity due to measurement error; office readings preferred

• Complete metabolic panel and renal function:
• Serum creatinine and calculated glomerular filtration rate: Baseline renal function; acute rise indicates acute kidney injury
• Blood urea nitrogen: Often disproportionately elevated (>30 mg/dL) compared to creatinine, reflecting acute glomerular injury
• Serum potassium: Hypokalemia suggests secondary hypertension (hyperaldosteronism, renal artery stenosis)
• Serum sodium: Hyponatremia may occur with SIADH from CNS injury

• Urinalysis and urine microscopy:
• Proteinuria, hematuria, RBC casts: Pathognomonic for glomerulonephritis or fibrinoid necrosis
• Dysmorphic RBCs: Indicate glomerular origin of hematuria
• Schistocytes (fragmented RBCs) on blood smear: Microangiopathic hemolytic anemia from mechanical trauma in damaged capillaries

• Complete blood count:
• Hemoglobin/hematocrit: Decreased with microangiopathic hemolytic anemia
• Platelet count: Decreased (thrombocytopenia) with consumption during fibrinoid necrosis
• Reticulocyte count: Elevated (>2%) with hemolysis

• Coagulation studies:
• PT/INR, activated partial thromboplastin time: Abnormalities suggest disseminated intravascular coagulation (DIC) in severe cases
• D-dimer, fibrinogen: Elevated D-dimer; low fibrinogen with DIC

• Cardiac and myocardial injury markers:
• Troponin I or T: Elevated if acute coronary syndrome present
• B-type natriuretic peptide (BNP) or NT-proBNP: Markedly elevated (>500 pg/mL) with acute heart failure

• Neuroimaging:
• Non-contrast head CT: Initial study to exclude intracranial hemorrhage; may show hypodensity in PRES distribution or ischemic stroke
• MRI brain with FLAIR and diffusion sequences: Preferred for detecting PRES (T2/FLAIR hyperintensities in parieto-occipital and temporal regions bilaterally); diffusion-weighted imaging identifies acute ischemia
• CT angiography chest: If aortic dissection suspected (Type B dissection presents with hypertensive emergency)

• Ophthalmologic examination:
• Fundoscopy: Essential to assess for papilledema (indicates true emergency), retinal hemorrhages, cotton-wool spots, hard exudates
• Presence of papilledema elevates diagnosis to hypertensive emergency even without other organ damage

• Electrocardiography:
• Left ventricular hypertrophy: Chronic adaptive change; PR prolongation, left axis deviation common
• ST-segment elevation or T-wave inversions: Acute coronary syndrome
• Atrial fibrillation: Secondary to acute atrial stretch from elevated pressures

• Diagnostic criteria for hypertensive emergency:
• Severe hypertension (SBP >180 mmHg or DBP >120 mmHg) AND
• Evidence of acute end-organ damage:
• Encephalopathy (altered mental status, headache, seizures, visual changes)
• Acute coronary syndrome (chest pain, troponin elevation, ECG changes)
• Acute pulmonary edema (dyspnea, crackles, elevated BNP)
• Acute stroke (focal neurologic deficit, imaging evidence)
• Acute kidney injury (creatinine elevation, proteinuria, hematuria, schistocytes)
• Microangiopathic hemolytic anemia (schistocytes, low platelets, elevated LDH, low haptoglobin)
• Aortic dissection (chest/back pain, pressure differential, imaging)

• Target blood pressure reduction strategy (critical principle):
• Initial goal: Reduce mean arterial pressure (MAP) by no more than 25% in first hour
• Rationale: Excessive reduction causes ischemia in organs accustomed to high perfusion pressures; gradual reduction allows autoregulation recovery
• Subsequent goal: Further reduction to 160/110 mmHg over 2-6 hours
• Exception: Acute ischemic stroke—target SBP <220 mmHg; hemorrhagic stroke—target SBP <180 mmHg more urgently
• Average reduction should not exceed 10-15 mmHg per hour after initial phase

• First-line intravenous antihypertensive agents (parenteral agents preferred for titratability):

• Nicardipine IV (dihydropyridine calcium channel blocker):
• Mechanism: Selective vascular smooth muscle relaxation via L-type calcium channel blockade; minimal myocardial depression
• Dosing: Initial 5 mg/hr IV infusion; titrate by 2.5 mg/hr every 5-15 minutes (max 15 mg/hr)
• Onset: 5-10 minutes; duration 30-40 minutes after discontinuation
• Advantages: Titratable, rapid onset/offset, maintains cerebral perfusion, does not impair renal function
• Preferred agent for most hypertensive emergencies

• Labetalol IV (combined α/β-blocker):
• Mechanism: 1:7 ratio of α to β blockade; reduces SVR without reflex tachycardia
• Dosing: 10-20 mg IV bolus over 2 minutes; repeat every 10 minutes up to 80 mg total, then 40-80 mg every 10 minutes; OR continuous infusion 0.5-2 mg/min
• Onset: 5-10 minutes (IV bolus); duration 3-6 hours
• Advantages: Maintains cardiac output, no reflex tachycardia
• Disadvantages: Contraindicated in acute decompensated heart failure (negative inotropy), asthma/COPD
• Avoid in: Bradycardia, AV block, acute cocaine use (unopposed α-blockade)

• Esmolol IV (ultra-short-acting β-blocker):
• Mechanism: Selective β1-adrenergic antagonism; reduces heart rate and contractility
• Dosing: 250-500 mcg/kg/min IV infusion, titrate to effect
• Onset: 1-2 minutes; offset <10 minutes (very short duration of action)
• Advantages: Rapid titration, ideal for acute coronary syndrome
• Disadvantages: Negative inotropy, reflex tachycardia if diastolic pressure reduced excessively
• Use in: Acute MI with hypertension, tachyarrhythmias

• Sodium nitroprusside IV (direct vasodilator):
• Mechanism: Nitric oxide donation causing smooth muscle relaxation in arteries and veins
• Dosing: 0.3-0.5 mcg/kg/min IV infusion; titrate by 0.5 mcg/kg/min every 5 minutes (max 10 mcg/kg/min)
• Onset: Immediate (1-2 minutes); offset <5 minutes
• Advantages: Potent, rapid titration, predictable
• Disadvantages: Cyanide toxicity with prolonged use (>4 hours); thiocyanate toxicity with renal dysfunction; requires arterial line monitoring; light-sensitive (wrap infusion)
• Reserve for: Aortic dissection, severe pulmonary edema (due to venous dilation), refractory cases
• Monitor: Thiocyanate levels if used >4-6 hours; serum creatinine for toxicity

• Hydralazine IV (direct arteriolar vasodilator):
• Mechanism: Direct smooth muscle relaxation; predominantly arterial effect
• Dosing: 5-10 mg IV bolus every 20-30 minutes (max 20 mg), OR 0.5-1.4 mg/kg/hr infusion
• Onset: 10-20 minutes; duration 4-6 hours
• Advantages: Safe in pregnancy (drug of choice for preeclampsia/ecl

Disease complications (all are emergencies requiring parenteral therapy)

• Intracranial hemorrhage: rupture of Charcot-Bouchard microaneurysms in penetrating lenticulostriate vessels; signaled by abrupt headache with vomiting and a focal deficit, with hyperdensity in the basal ganglia, thalamus, pons, or cerebellum on non-contrast CT.
• Hypertensive encephalopathy / PRES: breakthrough of cerebral autoregulation with vasogenic edema; signaled by insidious headache, confusion, cortical blindness, and seizures that resolve as pressure falls — a reversible syndrome, unlike infarction.
• Acute decompensated heart failure with flash pulmonary edema: abrupt afterload mismatch raises LV filling pressure; signaled by orthopnea, diffuse crackles, S3, and markedly elevated BNP.
• Acute coronary syndrome: demand ischemia from wall-stress-driven oxygen consumption plus plaque rupture; signaled by ischemic chest pain with troponin elevation and dynamic ST/T changes.
• Aortic dissection: intimal tear propagated by high pulsatile shear (dP/dt); signaled by tearing chest/back pain, pulse or blood-pressure differential, and new aortic regurgitation. The 2022 ACC/AHA aortic disease guideline calls for the most aggressive targets of any hypertensive emergency.
• Malignant nephrosclerosis with MAHA: fibrinoid necrosis of afferent arterioles shears erythrocytes; signaled by rising creatinine, hematuria with RBC casts, schistocytes, low haptoglobin, and thrombocytopenia. Mimics TTP — a common trap.
• Hypertensive retinopathy with papilledema: signaled by vision loss and flame hemorrhages with cotton-wool spots; papilledema alone establishes emergency status.

Treatment-related complications

• Iatrogenic hypotension from over-rapid lowering: chronically hypertensive patients have a right-shifted autoregulatory curve, so "normal" pressure is hypoperfusion — watershed infarction, ischemic optic neuropathy, MI, and AKI follow. This is why ACC/AHA limits the first-hour MAP drop to about 25%.
• Cyanide/thiocyanate toxicity with nitroprusside: signaled by altered mental status, high anion-gap lactic acidosis, and elevated mixed venous oxygen saturation; risk rises with high doses, prolonged infusion, and renal or hepatic impairment. Treat with hydroxocobalamin or sodium thiosulfate.
• Reflex tachycardia from pure vasodilators (hydralazine, nitroprusside, dihydropyridines): increases dP/dt and is hazardous in dissection and active ischemia.
• Unopposed alpha stimulation: beta blockade without prior alpha blockade in pheochromocytoma (or cocaine toxicity) can paradoxically worsen vasoconstriction.

• Emergency versus urgency is defined by end-organ damage, not by the number: a BP of 240/140 with a normal exam, normal creatinine, and no papilledema is urgency — per ACC/AHA, restart or intensify oral therapy and arrange close follow-up. The classic distractor is admitting these patients for an IV drip; acute lowering in urgency causes harm without benefit.
• Sublingual immediate-release nifedipine is always the wrong answer: uncontrolled precipitous drops have caused stroke and MI, and it is not recommended in any current guideline.
• The 25% rule: reduce MAP by no more than about 25% in the first hour. If a stem describes a neurologic deficit appearing after rapid normalization of pressure, the answer is iatrogenic cerebral hypoperfusion, not a new stroke from the hypertension itself.
• Aortic dissection is the exception to gentle lowering: the 2022 ACC/AHA aortic disease guideline calls for prompt reduction of heart rate and systolic pressure. Give a beta blocker (esmolol) first, then add a vasodilator — vasodilator alone triggers reflex tachycardia that raises dP/dt and extends the dissection.
• Pheochromocytoma: phenoxybenzamine or phentolamine before any beta blocker. Alpha blockade always precedes beta blockade.
• Cocaine or methamphetamine: benzodiazepines are the first step; phentolamine or nicardipine if pressure persists.
• Pregnancy: ACOG designates IV labetalol, IV hydralazine, or oral immediate-release nifedipine as first-line for acute severe hypertension, with magnesium sulfate for eclamptic seizure prophylaxis — magnesium is anticonvulsant, not antihypertensive. All ACE inhibitors, including captopril, are contraindicated in pregnancy.
• Stroke thresholds examiners love: per AHA/ASA, blood pressure must be below 185/110 mmHg before IV thrombolysis, and in non-thrombolysis ischemic stroke, permissive hypertension is allowed until pressure is extremely high, because lowering it compromises the ischemic penumbra.
• Nitroprusside pearls: cyanide toxicity with high-dose or prolonged infusion, thiocyanate accumulation in renal failure, and a tendency to raise intracranial pressure — reasons nicardipine or clevidipine is usually preferred in encephalopathy.